AavantiBio Competitors and Similar CompaniesClear all

AavantiBio's competitors and similar companies include Cambium Bio, BBI Life Sciences, Kolon Life Science and Canopy Biosciences.
AavantiBio
AavantiBio
AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space.
Cambium Bio
Cambium Bio
Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.
BBI Life Sciences
BBI Life Sciences
BBI Life Sciences (BBI生命科学) is a supplier of life science products and services.
Kolon Life Science
Kolon Life Science
Kolon Life Science is a cell and gene therapy company.
Canopy Biosciences
Canopy Biosciences
Canopy Biosciences is a life science company that provides research tools and services for genetic engineering, molecular biology, and personalized medicine.
Founding Date
Founding Date
2020
Founding Date
2007
Founding Date
2013
Founding Date
2000
Founding Date
2016
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Paddington, AU HQ
Pymble, AU
Locations
CN HQ
Locations
HQ
Locations
St. Louis, US HQ
Leipzig, DE
Hayward, US
Employees
Employees
6
Employees
N/A
Employees
1,588
Employees
563
Employees
244% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$670k (FY, 2025)
Revenue (est.)
¥703.8m (FY, 2019)
Revenue (est.)
₩124.6b (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥288m (FY, 2019)
Cost of goods
₩104.4b (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$1.2m (FY, 2025)
Gross profit
¥417.2m (FY, 2019)
Gross profit
₩20.5b (FY, 2023)
Gross profit
N/A
Net income
Net income
N/A
Net income
($3.8m) (FY, 2025)
Net income
¥86m (FY, 2019)
Net income
(₩33.6b) (FY, 2023)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 107m (over 5 years ago)
Latest funding round
N/A
Latest funding round
$ 10.3m (over 11 years ago)
Latest funding round
N/A
Latest funding round
$ 2.4m (almost 8 years ago)
Total funding raised
Total funding raised
$ 107m
Total funding raised
N/A
Total funding raised
$ 10.3m
Total funding raised
N/A
Total funding raised
$ 4.4m
For sources of this data, please see the company profile

View Company Profiles

Cambium Bio
HQ
Paddington, AU

Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.

View company
BBI Life Sciences
HQ
CN
Employees
1,588

BBI Life Sciences (BBI生命科学) is a supplier of life science products and services.

View company
Kolon Life Science
HQ
Employees
563

Kolon Life Science is a cell and gene therapy company.

View company
Canopy Biosciences
HQ
St. Louis, US
Employees
24↓ 4% decrease

Canopy Biosciences is a life science company that provides research tools and services for genetic engineering, molecular biology, and personalized medicine.

View company